Blood Cancer Awareness MonthSeptember 28, 2018September is 'blood cancer awareness month', and we had the opportunity to take part in a number of conferences, workshops and summits [...]
Trial in Focus – NHL30 (PETReA)August 28, 2018“If the study can confirm the benefit of a PET response adapted approach, it will establish a new standard of care for follicular [...]
ALLG and MRFF via CanTeen launch new clinical trial to improve the lives of young AustraliansJuly 31, 2018On Wednesday 25 July, Federal Health Minister Greg Hunt announced $3.2 million in funding to four clinical trials that will give [...]
Mr Peter Terence Kempen – Honorary Member in the General Division (AM)June 22, 2018On Monday 11 June, the Chairman of the ALLG, Mr Peter T Kempen was announced as an honorary Member (AM) in the general division of the [...]
May 2018 ALLG Scientific Meeting HighlightsMay 22, 2018The Australasian Leukaemia and Lymphoma Group (ALLG) held its May 2018 Scientific Meeting (SM) in Melbourne with 270 members in attendance.
Where to now for the Medical Research Future Fund (MRFF)?April 9, 2018Late last year the ALLG welcomed the release of the Select Committee report into Funding for Research into Cancers with Low Survival [...]
Vale Professor Michael PfreundschuhMarch 15, 2018Professor Michael Pfreundschuh, one of the leading experts in the world of Lymphoma research and treatment, sadly passed away on March [...]
The Importance of Clinical TrialsFebruary 28, 2018This year, almost 16,000 Australians will begin a long and gruelling journey with blood cancer. Decades of research have led to vastly [...]
Australasian Leukaemia and Lymphoma Group is registered with the Australian Taxation Office as an Income Tax Exempt Charitable Entity.
Memberships
Donations
Clinical Trials & Research